RaySearch Laboratories AB announced an extension of its relationship with Centre hospitalier universitaire vaudois (CHUV) in Lausanne, Switzerland, which will include orders for RayStation RayCare and RayIntelligence. 

June 28, 2021 — RaySearch Laboratories AB announced an extension of its relationship with Centre hospitalier universitaire vaudois (CHUV) in Lausanne, Switzerland, which will include orders for RayStation RayCare and RayIntelligence. 

CHUV has been a RayStation customer since 2017 and included in the order is additional RayStation functionality for automated treatment planning and segmentation using machine learning techniques and support for CyberKnife planning. CHUV will become one of the first centers to adopt RayStation’s planning functionality for the Accuray CyberKnife treatment delivery system.

The center will also fully replace its existing oncology information system with RayCare to coordinate and optimize its workflows and treatment management.

In addition, CHUV will be the first center to purchase RayIntelligence, the innovative cloud-based oncology analytics system launched in December 2020. The system simplifies data integration and supports analysis of patient and treatment populations, research activities and workflows.

Going forward, CHUV will conduct all major radiation oncology activities including treatment planning, record and verify, workflow management and data analytics exclusively with RaySearch software.

RaySearch and CHUV will also work togheter on various dimensions of treatment optimization,  operational efficiency including optimal machine utilization and the new treatment technique FLASH radiotherapy. CHUV has pioneered the development of this new technique which makes it possible to deliver the required dose to the patient in a few sessions each lasting a few seconds, rather than in conventional treatments requiring multiple sessions of several minutes.

Prof. Jean Bourhis, CHUV says: “The collaboration between RaySearch and CHUV is entering in a very promising phase, setting up at CHUV a single integrated software platform, connecting all our radiation oncology activities and combining a highly efficient digital workflow management, along with innovative artificial intelligence tools for contouring and dosimetry. We expect to markedly improve the global efficiency, along with increasing the quality and safety of our radiation oncology treatments”.

Johan Löf, founder and CEO, RaySearch, said: “We are very pleased to extend our relationship with CHUV, a world-class center with a focus on using advanced technology to benefit patients. By expanding the existing RayStation installation to a complete suite of RaySearch products at CHUV, we will be able to support an optimization of operational efficiency, improve treatment quality and through RayIntelligence capture all data for improved decision making and further personalize treatments”.

The combined order value is 1,8 M EURO excluding service agreement.

For more information: www.raysearchlabs.com

Related Content

News | Lung Imaging

October 11, 2021 — According to ARRS’ American Journal of Roentgenology (AJR), percutaneous image-guided microwave and ...

Time October 11, 2021
arrow
News | Women's Health

October 8, 2021 — An analysis of nearly 200,000 patients who received mammograms between 2006 and 2015 across three U.S ...

Time October 08, 2021
arrow
News | Radiation Therapy

October 7, 2021 — NANOBIOTIX, a late-stage clinical biotechnology company pioneering physics-based approaches to expand ...

Time October 07, 2021
arrow
News | Radiation Therapy

October 7, 2021 — ViewRay, Inc. announced that the company has received acceptance from the FDA on their recent ...

Time October 07, 2021
arrow
News | Women's Health

October 5, 2021 — A promising radionuclide treatment may offer new therapeutic options for breast cancer patients ...

Time October 05, 2021
arrow
Feature | Radiation Therapy | By Dave Fornell

To maintain safety in radiation therapy (RT), every machine performance and patient delivery measurement must be as ...

Time October 05, 2021
arrow
News | Radiation Oncology

September 28, 2021 — The global radiotherapy devices market is expected to grow from $5.44 billion in 2020 to $5.848 ...

Time September 28, 2021
arrow
News | Prostate Cancer

September 24, 2021 — Scientists have identified two subtypes of metastatic prostate cancer that respond differently to ...

Time September 24, 2021
arrow
News | Artificial Intelligence

September 24, 2021 — Owkin, a startup that deploys artificial intelligence (AI) and Federated Learning technologies to ...

Time September 24, 2021
arrow
News | Radiation Therapy

September 24, 2021 — The "Global Surface Guided Radiation Therapy (SGRT) Devices Market, By Device Type (Portable v/s ...

Time September 24, 2021
arrow
Subscribe Now